Concepedia

Sayaka Nagami

SN

Statistics

Publications

4

Citations

206

H-Index

4

Active since

2018

Affiliations

Nara Medical University(Current)

St. Marianna University School of Medicine

Ogikubo Hospital

National Center For Child Health and Development

Sayaka Nagami is an author at Nara Medical University specializing in hematology, pharmacotherapy, and pharmacodynamic modeling.

ORCID

Top concepts

Publications per year

2018–2021

4

Publications

4

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

Midori Shima, Keiji Nogami, Sayaka Nagami et al. · Haemophilia · 2019 · 148 citations · Full text

Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients’ perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A

Midori Shima, Azusa Nagao, Masashi Taki et al. · Haemophilia · 2020 · 36 citations · Full text

Every 2 Weeks or Every 4 Weeks Subcutaneous Injection of Emicizumab in Pediatric Patients with Severe Hemophilia A without Inhibitors: A Multi-Center, Open-Label Study in Japan (HOHOEMI Study)

Midori Shima, Keiji Nogami, Sayaka Nagami et al. · Blood · 2018 · 11 citations

A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A

Koichiro Yoneyama, Christophe Schmitt, Tiffany Chang et al. · The Journal of Clinical Pharmacology · 2021 · 11 citations · Full text

, , +13

1–4 of 4